Medtronic delivers business value through product and packaging improvements that conserve natural resources, increase ...
Expanding the long-running partnership will bring Medtronic technologies, such as the Nellcor pulse oximetry product, to more healthcare settings.
Medtronic (NYSE:MDT) continues to lead in medical technology, making significant contributions to the S&P 500 Chart ...
Medtronic ended its fiscal year with nominal sales growth and a steep profit drop, but analysts who cover the medical device company are confident a windfall is ahead, thanks to a strong lineup of ...
Two patients who were injured by Medtronic's controversial Infuse bone graft product will receive a combined $8.45 million in settlements with the University of California Los Angeles, where a doctor ...
The Star Tribune interviewed a couple of “co-authors” to a disputed study of Medtronic‘s bone-growth product Infuse. A former military surgeon, Dr. Timothy Kuklo, is accused by a former supervisor of ...
Medtronic plc reported Q2 earnings today, with revenues of $8.4bn, up 5% year-on-year, adjusted EPS of $1.26, supported by a dividend yielding 3.2%. Despite consistent mid-single-digit revenue growth ...
Medtronic delivers business value through product and packaging improvements that conserve natural resources, increase recyclability, and help minimize emissions and waste. NORTHAMPTON, MA / ACCESS Ne ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results